Published in Exp Ther Med on September 06, 2016
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med (2007) 47.86
The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med (2004) 18.60
A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med (2008) 17.19
The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med (2004) 17.08
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J (2004) 16.84
Development and first validation of the COPD Assessment Test. Eur Respir J (2009) 8.06
Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J (2006) 6.34
Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. N Engl J Med (2000) 5.65
Evaluation of clinical methods for rating dyspnea. Chest (1988) 4.12
Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J (2006) 3.89
Risk for death associated with medications for recently diagnosed chronic obstructive pulmonary disease. Ann Intern Med (2008) 3.60
Chronic obstructive pulmonary disease. Lancet (2003) 2.64
Effects of smoking and solid-fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modelling study. Lancet (2008) 2.27
Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1998) 2.01
Six-minute walk test: a valuable tool for assessing pulmonary impairment. J Bras Pneumol (2011) 1.64
Chemical constituents and pharmacological properties of Poria cocos. Planta Med (2011) 1.14
Use of inhaled and oral corticosteroids and the long-term risk of cataract. Ophthalmology (2009) 1.13
New combination bronchodilators for chronic obstructive pulmonary disease: current evidence and future perspectives. Br J Clin Pharmacol (2015) 1.10
Is enough attention being given to the adverse effects of corticosteroid therapy? J Clin Pharm Ther (2000) 1.05
Screening for the anti-inflammatory activity of fractions and compounds from Atractylodes macrocephala koidz. J Ethnopharmacol (2007) 1.03
Inhaled and systemic corticosteroids in chronic obstructive pulmonary disease. Proc Am Thorac Soc (2008) 0.99
Health-related quality of life in individuals with chronic obstructive pulmonary disease. Heart Lung (2005) 0.98
Effect of a Three-Week Inpatient Rehabilitation Program on 544 Consecutive Patients with Very Severe COPD: A Retrospective Analysis. Respiration (2015) 0.91
Cigarette smoke exposure exacerbates lung inflammation and compromises immunity to bacterial infection. J Immunol (2014) 0.91
Potential adverse effects of bronchodilators in the treatment of airways obstruction in older people: recommendations for prescribing. Drugs Aging (2008) 0.89
Viral infection is associated with an increased proinflammatory response in chronic obstructive pulmonary disease. Viral Immunol (2012) 0.86
Atractylodes japonica Koidzumi inhibits the production of proinflammatory cytokines through inhibition of the NF-kappaB/IkappaB signal pathway in HMC-1 human mast cells. Arch Pharm Res (2010) 0.85
Dynamics of regulatory T-cells during pregnancy: effect of HIV infection and correlations with other immune parameters. PLoS One (2011) 0.83
[Clinical significance of acute exacerbation in chronic obstructive pulmonary disease]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue (2007) 0.82
Echinocystic acid, a metabolite of lancemaside A, inhibits TNBS-induced colitis in mice. Int Immunopharmacol (2013) 0.81
p38 MAPK signal pathway involved in anti-inflammatory effect of Chaihu-Shugan-San and Shen-ling-bai-zhu-San on hepatocyte in non-alcoholic steatohepatitis rats. Afr J Tradit Complement Altern Med (2013) 0.81
Codonopsis pilosula polysaccharide attenuates cecal ligation and puncture sepsis via circuiting regulatory T cells in mice. Shock (2014) 0.80
The Immunoregulatory Effects of Traditional Chinese Medicine on Treatment of Asthma or Asthmatic Inflammation. Am J Chin Med (2015) 0.79
Study of body composition, lung function, and quality of life following use of anabolic steroids in patients with chronic obstructive pulmonary disease. Nutr Clin Pract (2014) 0.78
Treatment of chronic bronchitis with modified ma xing shi gan tang and er chen tang. J Tradit Chin Med (2004) 0.78
[Clinical study of allergic rhinitis treated by "bu qi gu biao" therapy]. Zhong Xi Yi Jie He Za Zhi (1989) 0.78
Effectiveness and safety of traditional Chinese medicine on stable chronic obstructive pulmonary disease: A systematic review and meta-analysis. Complement Ther Med (2015) 0.77
The effect of induced sputum and bronchoalveolar lavage fluid from patients with chronic obstructive pulmonary disease on neutrophil migration in vitro. Medicina (Kaunas) (2010) 0.77
Viral Profile of COPD Exacerbations According to Patients. Open Respir Med J (2015) 0.76
[Impact of Chinese herb on quality of life of stable chronic obstructive pulmonary disease: a randomized controlled study]. Zhongguo Zhong Yao Za Zhi (2011) 0.76